Every morning for the past two years, on waking, I’ve reached out for the white plastic tub on the bedside table, shaken out four oval white tablets into the lid, tossed them into my mouth, and washed them down with a pint of water. Initially I counted myself lucky to be selected to take the expensive drug abiraterone for two years as part of a nationwide clinical trial.
Already a subscriber? Log in
Subscribe for just $2 a week
Try a month of The Spectator Australia absolutely free and without commitment. Not only that but – if you choose to continue – you’ll pay just $2 a week for your first year.
- Unlimited access to spectator.com.au and app
- The weekly edition on the Spectator Australia app
- Spectator podcasts and newsletters
- Full access to spectator.co.uk
Or
Unlock this article
You might disagree with half of it, but you’ll enjoy reading all of it. Try your first month for free, then just $2 a week for the remainder of your first year.
Comments
Don't miss out
Join the conversation with other Spectator Australia readers. Subscribe to leave a comment.
SUBSCRIBEAlready a subscriber? Log in